Affectis Pharmaceuticals
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.
B2X
Country
Founded Date
2002
Headquarters
Investors
Latest Funding Round Date
March 22, 2010
Latest Funding Round Amount (USD)
350,000
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
21,000,000
Official Website
Find more companies like Affectis Pharmaceuticals
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
